世界の気管支炎治療薬市場予測2023-2029：抗生物質、抗アレルギー薬（抗ヒスタミン薬）、気管支拡張薬、粘液溶解薬、その他

【英語タイトル】Bronchitis Treatment Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23FB2166）

・商品コード：MMG23FB2166
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年2月
・ページ数：66
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の気管支炎治療薬市場規模と予測を収録しています。・世界の気管支炎治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の気管支炎治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の気管支炎治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「抗生物質」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

気管支炎治療薬のグローバル主要企業は、Astrazeneca、Bayer Ag、Boehringer Ingelheim International Gmbh、Cipla Inc.、Dr. Reddy's Laboratories Ltd.、Glaxosmithkline Plc、Merck & Co. Inc.、Novartis Ag、Pfizer Inc.、Sanofi、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、Melinta Therapeuticsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、気管支炎治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の気管支炎治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の気管支炎治療薬市場：タイプ別市場シェア、2022年
・抗生物質、抗アレルギー薬（抗ヒスタミン薬）、気管支拡張薬、粘液溶解薬、その他

世界の気管支炎治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の気管支炎治療薬市場：用途別市場シェア、2022年
・急性気管支炎、慢性気管支炎

世界の気管支炎治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の気管支炎治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における気管支炎治療薬のグローバル売上、2018年-2023年
・主要企業における気管支炎治療薬のグローバル売上シェア、2022年
・主要企業における気管支炎治療薬のグローバル販売量、2018年-2023年
・主要企業における気管支炎治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Astrazeneca、Bayer Ag、Boehringer Ingelheim International Gmbh、Cipla Inc.、Dr. Reddy’s Laboratories Ltd.、Glaxosmithkline Plc、Merck & Co. Inc.、Novartis Ag、Pfizer Inc.、Sanofi、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、Melinta Therapeutics

*************************************************************

・調査・分析レポートの概要
気管支炎治療薬市場の定義
市場セグメント
世界の気管支炎治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の気管支炎治療薬市場規模
世界の気管支炎治療薬市場規模：2022年 VS 2029年
世界の気管支炎治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの気管支炎治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の気管支炎治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：抗生物質、抗アレルギー薬（抗ヒスタミン薬）、気管支拡張薬、粘液溶解薬、その他
気管支炎治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：急性気管支炎、慢性気管支炎
気管支炎治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別気管支炎治療薬市場規模 2022年と2029年
地域別気管支炎治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Astrazeneca、Bayer Ag、Boehringer Ingelheim International Gmbh、Cipla Inc.、Dr. Reddy’s Laboratories Ltd.、Glaxosmithkline Plc、Merck & Co. Inc.、Novartis Ag、Pfizer Inc.、Sanofi、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、Melinta Therapeutics
…

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Bronchitis Treatment Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bronchitis Treatment Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bronchitis Treatment Drug Overall Market Size
2.1 Global Bronchitis Treatment Drug Market Size: 2022 VS 2029
2.2 Global Bronchitis Treatment Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Bronchitis Treatment Drug Players in Global Market
3.2 Top Global Bronchitis Treatment Drug Companies Ranked by Revenue
3.3 Global Bronchitis Treatment Drug Revenue by Companies
3.4 Top 3 and Top 5 Bronchitis Treatment Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Bronchitis Treatment Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bronchitis Treatment Drug Players in Global Market
3.6.1 List of Global Tier 1 Bronchitis Treatment Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Bronchitis Treatment Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Bronchitis Treatment Drug Market Size Markets, 2022 & 2029
4.1.2 Antibiotics
4.1.3 Anti-allergy Drugs (Antihistamines)
4.1.4 Bronchodilators
4.1.5 Mucolytics
4.1.6 Others
4.2 By Type – Global Bronchitis Treatment Drug Revenue & Forecasts
4.2.1 By Type – Global Bronchitis Treatment Drug Revenue, 2018-2023
4.2.2 By Type – Global Bronchitis Treatment Drug Revenue, 2024-2029
4.2.3 By Type – Global Bronchitis Treatment Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Bronchitis Treatment Drug Market Size, 2022 & 2029
5.1.2 Acute Bronchitis
5.1.3 Chronic Bronchitis
5.2 By Application – Global Bronchitis Treatment Drug Revenue & Forecasts
5.2.1 By Application – Global Bronchitis Treatment Drug Revenue, 2018-2023
5.2.2 By Application – Global Bronchitis Treatment Drug Revenue, 2024-2029
5.2.3 By Application – Global Bronchitis Treatment Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Bronchitis Treatment Drug Market Size, 2022 & 2029
6.2 By Region – Global Bronchitis Treatment Drug Revenue & Forecasts
6.2.1 By Region – Global Bronchitis Treatment Drug Revenue, 2018-2023
6.2.2 By Region – Global Bronchitis Treatment Drug Revenue, 2024-2029
6.2.3 By Region – Global Bronchitis Treatment Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Bronchitis Treatment Drug Revenue, 2018-2029
6.3.2 US Bronchitis Treatment Drug Market Size, 2018-2029
6.3.3 Canada Bronchitis Treatment Drug Market Size, 2018-2029
6.3.4 Mexico Bronchitis Treatment Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Bronchitis Treatment Drug Revenue, 2018-2029
6.4.2 Germany Bronchitis Treatment Drug Market Size, 2018-2029
6.4.3 France Bronchitis Treatment Drug Market Size, 2018-2029
6.4.4 U.K. Bronchitis Treatment Drug Market Size, 2018-2029
6.4.5 Italy Bronchitis Treatment Drug Market Size, 2018-2029
6.4.6 Russia Bronchitis Treatment Drug Market Size, 2018-2029
6.4.7 Nordic Countries Bronchitis Treatment Drug Market Size, 2018-2029
6.4.8 Benelux Bronchitis Treatment Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Bronchitis Treatment Drug Revenue, 2018-2029
6.5.2 China Bronchitis Treatment Drug Market Size, 2018-2029
6.5.3 Japan Bronchitis Treatment Drug Market Size, 2018-2029
6.5.4 South Korea Bronchitis Treatment Drug Market Size, 2018-2029
6.5.5 Southeast Asia Bronchitis Treatment Drug Market Size, 2018-2029
6.5.6 India Bronchitis Treatment Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Bronchitis Treatment Drug Revenue, 2018-2029
6.6.2 Brazil Bronchitis Treatment Drug Market Size, 2018-2029
6.6.3 Argentina Bronchitis Treatment Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Bronchitis Treatment Drug Revenue, 2018-2029
6.7.2 Turkey Bronchitis Treatment Drug Market Size, 2018-2029
6.7.3 Israel Bronchitis Treatment Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Bronchitis Treatment Drug Market Size, 2018-2029
6.7.5 UAE Bronchitis Treatment Drug Market Size, 2018-2029
7 Bronchitis Treatment Drug Companies Profiles
7.1 Astrazeneca
7.1.1 Astrazeneca Company Summary
7.1.2 Astrazeneca Business Overview
7.1.3 Astrazeneca Bronchitis Treatment Drug Major Product Offerings
7.1.4 Astrazeneca Bronchitis Treatment Drug Revenue in Global Market (2018-2023)
7.1.5 Astrazeneca Key News & Latest Developments
7.2 Bayer Ag
7.2.1 Bayer Ag Company Summary
7.2.2 Bayer Ag Business Overview
7.2.3 Bayer Ag Bronchitis Treatment Drug Major Product Offerings
7.2.4 Bayer Ag Bronchitis Treatment Drug Revenue in Global Market (2018-2023)
7.2.5 Bayer Ag Key News & Latest Developments
7.3 Boehringer Ingelheim International Gmbh
7.3.1 Boehringer Ingelheim International Gmbh Company Summary
7.3.2 Boehringer Ingelheim International Gmbh Business Overview
7.3.3 Boehringer Ingelheim International Gmbh Bronchitis Treatment Drug Major Product Offerings
7.3.4 Boehringer Ingelheim International Gmbh Bronchitis Treatment Drug Revenue in Global Market (2018-2023)
7.3.5 Boehringer Ingelheim International Gmbh Key News & Latest Developments
7.4 Cipla Inc.
7.4.1 Cipla Inc. Company Summary
7.4.2 Cipla Inc. Business Overview
7.4.3 Cipla Inc. Bronchitis Treatment Drug Major Product Offerings
7.4.4 Cipla Inc. Bronchitis Treatment Drug Revenue in Global Market (2018-2023)
7.4.5 Cipla Inc. Key News & Latest Developments
7.5 Dr. Reddy’s Laboratories Ltd.
7.5.1 Dr. Reddy’s Laboratories Ltd. Company Summary
7.5.2 Dr. Reddy’s Laboratories Ltd. Business Overview
7.5.3 Dr. Reddy’s Laboratories Ltd. Bronchitis Treatment Drug Major Product Offerings
7.5.4 Dr. Reddy’s Laboratories Ltd. Bronchitis Treatment Drug Revenue in Global Market (2018-2023)
7.5.5 Dr. Reddy’s Laboratories Ltd. Key News & Latest Developments
7.6 Glaxosmithkline Plc
7.6.1 Glaxosmithkline Plc Company Summary
7.6.2 Glaxosmithkline Plc Business Overview
7.6.3 Glaxosmithkline Plc Bronchitis Treatment Drug Major Product Offerings
7.6.4 Glaxosmithkline Plc Bronchitis Treatment Drug Revenue in Global Market (2018-2023)
7.6.5 Glaxosmithkline Plc Key News & Latest Developments
7.7 Merck & Co. Inc.
7.7.1 Merck & Co. Inc. Company Summary
7.7.2 Merck & Co. Inc. Business Overview
7.7.3 Merck & Co. Inc. Bronchitis Treatment Drug Major Product Offerings
7.7.4 Merck & Co. Inc. Bronchitis Treatment Drug Revenue in Global Market (2018-2023)
7.7.5 Merck & Co. Inc. Key News & Latest Developments
7.8 Novartis Ag
7.8.1 Novartis Ag Company Summary
7.8.2 Novartis Ag Business Overview
7.8.3 Novartis Ag Bronchitis Treatment Drug Major Product Offerings
7.8.4 Novartis Ag Bronchitis Treatment Drug Revenue in Global Market (2018-2023)
7.8.5 Novartis Ag Key News & Latest Developments
7.9 Pfizer Inc.
7.9.1 Pfizer Inc. Company Summary
7.9.2 Pfizer Inc. Business Overview
7.9.3 Pfizer Inc. Bronchitis Treatment Drug Major Product Offerings
7.9.4 Pfizer Inc. Bronchitis Treatment Drug Revenue in Global Market (2018-2023)
7.9.5 Pfizer Inc. Key News & Latest Developments
7.10 Sanofi
7.10.1 Sanofi Company Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Bronchitis Treatment Drug Major Product Offerings
7.10.4 Sanofi Bronchitis Treatment Drug Revenue in Global Market (2018-2023)
7.10.5 Sanofi Key News & Latest Developments
7.11 Sun Pharmaceutical Industries Ltd.
7.11.1 Sun Pharmaceutical Industries Ltd. Company Summary
7.11.2 Sun Pharmaceutical Industries Ltd. Business Overview
7.11.3 Sun Pharmaceutical Industries Ltd. Bronchitis Treatment Drug Major Product Offerings
7.11.4 Sun Pharmaceutical Industries Ltd. Bronchitis Treatment Drug Revenue in Global Market (2018-2023)
7.11.5 Sun Pharmaceutical Industries Ltd. Key News & Latest Developments
7.12 Teva Pharmaceutical Industries Ltd.
7.12.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.12.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.12.3 Teva Pharmaceutical Industries Ltd. Bronchitis Treatment Drug Major Product Offerings
7.12.4 Teva Pharmaceutical Industries Ltd. Bronchitis Treatment Drug Revenue in Global Market (2018-2023)
7.12.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.13 Melinta Therapeutics
7.13.1 Melinta Therapeutics Company Summary
7.13.2 Melinta Therapeutics Business Overview
7.13.3 Melinta Therapeutics Bronchitis Treatment Drug Major Product Offerings
7.13.4 Melinta Therapeutics Bronchitis Treatment Drug Revenue in Global Market (2018-2023)
7.13.5 Melinta Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Bronchitis Treatment Drug Market Opportunities & Trends in Global Market
Table 2. Bronchitis Treatment Drug Market Drivers in Global Market
Table 3. Bronchitis Treatment Drug Market Restraints in Global Market
Table 4. Key Players of Bronchitis Treatment Drug in Global Market
Table 5. Top Bronchitis Treatment Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Bronchitis Treatment Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Bronchitis Treatment Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Bronchitis Treatment Drug Product Type
Table 9. List of Global Tier 1 Bronchitis Treatment Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bronchitis Treatment Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Bronchitis Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Bronchitis Treatment Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Bronchitis Treatment Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Bronchitis Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Bronchitis Treatment Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Bronchitis Treatment Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Bronchitis Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Bronchitis Treatment Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Bronchitis Treatment Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Bronchitis Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Bronchitis Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Bronchitis Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Bronchitis Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Bronchitis Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 30. Astrazeneca Company Summary
Table 31. Astrazeneca Bronchitis Treatment Drug Product Offerings
Table 32. Astrazeneca Bronchitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Astrazeneca Key News & Latest Developments
Table 34. Bayer Ag Company Summary
Table 35. Bayer Ag Bronchitis Treatment Drug Product Offerings
Table 36. Bayer Ag Bronchitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer Ag Key News & Latest Developments
Table 38. Boehringer Ingelheim International Gmbh Company Summary
Table 39. Boehringer Ingelheim International Gmbh Bronchitis Treatment Drug Product Offerings
Table 40. Boehringer Ingelheim International Gmbh Bronchitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Boehringer Ingelheim International Gmbh Key News & Latest Developments
Table 42. Cipla Inc. Company Summary
Table 43. Cipla Inc. Bronchitis Treatment Drug Product Offerings
Table 44. Cipla Inc. Bronchitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Cipla Inc. Key News & Latest Developments
Table 46. Dr. Reddy's Laboratories Ltd. Company Summary
Table 47. Dr. Reddy's Laboratories Ltd. Bronchitis Treatment Drug Product Offerings
Table 48. Dr. Reddy's Laboratories Ltd. Bronchitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Dr. Reddy's Laboratories Ltd. Key News & Latest Developments
Table 50. Glaxosmithkline Plc Company Summary
Table 51. Glaxosmithkline Plc Bronchitis Treatment Drug Product Offerings
Table 52. Glaxosmithkline Plc Bronchitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Glaxosmithkline Plc Key News & Latest Developments
Table 54. Merck & Co. Inc. Company Summary
Table 55. Merck & Co. Inc. Bronchitis Treatment Drug Product Offerings
Table 56. Merck & Co. Inc. Bronchitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Merck & Co. Inc. Key News & Latest Developments
Table 58. Novartis Ag Company Summary
Table 59. Novartis Ag Bronchitis Treatment Drug Product Offerings
Table 60. Novartis Ag Bronchitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Novartis Ag Key News & Latest Developments
Table 62. Pfizer Inc. Company Summary
Table 63. Pfizer Inc. Bronchitis Treatment Drug Product Offerings
Table 64. Pfizer Inc. Bronchitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Inc. Key News & Latest Developments
Table 66. Sanofi Company Summary
Table 67. Sanofi Bronchitis Treatment Drug Product Offerings
Table 68. Sanofi Bronchitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Sanofi Key News & Latest Developments
Table 70. Sun Pharmaceutical Industries Ltd. Company Summary
Table 71. Sun Pharmaceutical Industries Ltd. Bronchitis Treatment Drug Product Offerings
Table 72. Sun Pharmaceutical Industries Ltd. Bronchitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 73. Sun Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 74. Teva Pharmaceutical Industries Ltd. Company Summary
Table 75. Teva Pharmaceutical Industries Ltd. Bronchitis Treatment Drug Product Offerings
Table 76. Teva Pharmaceutical Industries Ltd. Bronchitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 78. Melinta Therapeutics Company Summary
Table 79. Melinta Therapeutics Bronchitis Treatment Drug Product Offerings
Table 80. Melinta Therapeutics Bronchitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 81. Melinta Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Bronchitis Treatment Drug Segment by Type in 2022
Figure 2. Bronchitis Treatment Drug Segment by Application in 2022
Figure 3. Global Bronchitis Treatment Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Bronchitis Treatment Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Bronchitis Treatment Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bronchitis Treatment Drug Revenue in 2022
Figure 8. By Type - Global Bronchitis Treatment Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Bronchitis Treatment Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Bronchitis Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Bronchitis Treatment Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Bronchitis Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Bronchitis Treatment Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Bronchitis Treatment Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Bronchitis Treatment Drug Revenue Market Share, 2018-2029
Figure 16. US Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Bronchitis Treatment Drug Revenue Market Share, 2018-2029
Figure 20. Germany Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Bronchitis Treatment Drug Revenue Market Share, 2018-2029
Figure 28. China Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Bronchitis Treatment Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Bronchitis Treatment Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Bronchitis Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Astrazeneca Bronchitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer Ag Bronchitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Boehringer Ingelheim International Gmbh Bronchitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cipla Inc. Bronchitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Dr. Reddy's Laboratories Ltd. Bronchitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Glaxosmithkline Plc Bronchitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Merck & Co. Inc. Bronchitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novartis Ag Bronchitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Inc. Bronchitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sanofi Bronchitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Sun Pharmaceutical Industries Ltd. Bronchitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Teva Pharmaceutical Industries Ltd. Bronchitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Melinta Therapeutics Bronchitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

★調査レポート[世界の気管支炎治療薬市場予測2023-2029：抗生物質、抗アレルギー薬（抗ヒスタミン薬）、気管支拡張薬、粘液溶解薬、その他] (コード：MMG23FB2166)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界の気管支炎治療薬市場予測2023-2029：抗生物質、抗アレルギー薬（抗ヒスタミン薬）、気管支拡張薬、粘液溶解薬、その他]についてメールでお問い合わせ

MarketReport.jp

世界の気管支炎治療薬市場予測2023-2029：抗生物質、抗アレルギー薬（抗ヒスタミン薬）、気管支拡張薬、粘液溶解薬、その他

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料 総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp